Flovagatran

DB05714ExperimentalSmall molecule

Investigated for use/treatment in thrombosis.

Chemical structure of Flovagatran
Primary indication
Investigated for use/treatment in thrombosis.Curator reviewed
Formula / weight
C27H36BN3O7 · 525.41 g/mol (avg)
Code names
TGN 255

Resolves to

Compound
UNII2WA50NUH6HCAS871576-03-3
Structure
InChIKeyPAOGOXGDGABPSC-SGNDLWITSA-NSMILESCOCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](CC1=CC=CC=C1)NC(=O)OCC1=CC=CC=C1)B(O)O
Targets
P00734F2

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above

Which drugs share a target with Flovagatran, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In